Stocks & Investing
Thu, September 19, 2024
[ 12:00 AM ] - WOPRAI
Mon, September 16, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, July 31, 2024
[ 12:00 AM ] - WOPRAI
Mon, July 8, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 3, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 18, 2024
[ 12:00 AM ] - WOPRAI
Mon, May 13, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, March 21, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
Fri, October 27, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 11, 2023
[ 12:00 AM ] - WOPRAI
Mon, June 12, 2023
[ 12:00 AM ] - WOPRAI
Fri, June 2, 2023
[ 12:00 AM ] - WOPRAI
Fri, May 26, 2023
[ 12:00 AM ] - WOPRAI
Mon, May 15, 2023
[ 12:00 AM ] - WOPRAI
Thu, May 11, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 9, 2023
[ 12:00 AM ] - WOPRAI
Mon, May 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 24, 2023
[ 12:00 AM ] - WOPRAI
Fri, February 3, 2023
[ 12:00 AM ] - WOPRAI
Thu, December 22, 2022
Mon, November 14, 2022
[ 12:00 AM ] - WOPRAI
Thu, November 10, 2022
[ 12:00 AM ] - WOPRAI
Wed, November 2, 2022
Tue, September 6, 2022
[ 12:00 AM ] - WOPRAI
Fri, July 8, 2022
[ 12:00 AM ] - WOPRAI
Tue, April 12, 2022 Matthew Biegler Maintained (TYRA) at Buy with Increased Target to $33 on, Sep 19th, 2024
Matthew Biegler of Oppenheimer, Maintained "Tyra Biosciences, Inc." (TYRA) at Buy with Increased Target from $25 to $33 on, Sep 19th, 2024.
Matthew has made no other calls on TYRA in the last 4 months.
There are 3 other peers that have a rating on TYRA. Out of the 3 peers that are also analyzing TYRA, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $33 on, Thursday, August 15th, 2024
- Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $28 on, Thursday, August 8th, 2024
- Mitchell Kapoor of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Wednesday, July 3rd, 2024
